Atkinson Edward Morrow III 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 26, 2025
Insider Transaction Report
Form 4
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
- Tax Payment
Common Stock
2025-02-24$483.28/sh−1,656$800,312→ 26,251 total - Sale
Common Stock
2025-02-25$480.95/sh−1,767$849,839→ 24,484 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.